Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Puma"
82
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT03713931
Unknown
PUMA Implementation 2
AstraZeneca
ClinicalTrials.gov
NCT03713931
Unknown
-
PUMA Implementation 2
AstraZeneca
NCT03466944
Unknown
PUMA (Paediatric Osseous Marrow Assessment)
Institute of Cancer Research, United Kingdom
ClinicalTrials.gov
NCT03466944
Unknown
-
PUMA (Paediatric Osseous Marrow Assessment)
Institute of Cancer Resea...
NCT06423612
Recruiting
Not Applicable
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA)
Desmond Tutu HIV Foundation
ClinicalTrials.gov
NCT06423612
Recruiting
Not Applicable
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care U...
Desmond Tutu HIV Foundati...
2023-509707-32-00
Active Not Recruiting
Phase 2
Pembrolizumab for locally advanced, irresectable, non-metastatic dMMR colorectal cancers. The PUMA study.
-
CTIS (EMA)
2023-509707-32-00
Active Not Recruiting
Phase 2
Pembrolizumab for locally advanced, irresectable, non-metastatic dMMR colorectal...
-
NCT01372865
Completed
Phase 3
A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)
Eurofarma Laboratorios S.A.
ClinicalTrials.gov
NCT01372865
Completed
Phase 3
A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinniti...
Eurofarma Laboratorios S....
NCT01627314
Terminated
Phase 2
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.
Fate Therapeutics
ClinicalTrials.gov
NCT01627314
Terminated
Phase 2
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as...
Fate Therapeutics
NCT05966311
Recruiting
Not Applicable
Pediatric Percutaneous Ultrasound Gastrostomy Technique
Children's Hospital of Philadelphia
ClinicalTrials.gov
NCT05966311
Recruiting
Not Applicable
Pediatric Percutaneous Ultrasound Gastrostomy Technique
Children's Hospital of Ph...
NCT03935464
Completed
Not Applicable
Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of Tenofovir in PrEP
Kenya Medical Research Institute
ClinicalTrials.gov
NCT03935464
Completed
Not Applicable
Point-of-care Urine Monitoring of Adherence: Testing a Real-Time Urine Assay of...
Kenya Medical Research In...
NCT04156711
Completed
Not Applicable
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
Zealand University Hospital
ClinicalTrials.gov
NCT04156711
Completed
Not Applicable
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Sur...
Zealand University Hospit...
NCT04443959
Completed
Not Applicable
Telemedicine Mindfulness-based Therapy for Perinatal Insomnia: An Open-label Trial.
Henry Ford Health System
ClinicalTrials.gov
NCT04443959
Completed
Not Applicable
Telemedicine Mindfulness-based Therapy for Perinatal Insomnia: An Open-label Tri...
Henry Ford Health System
NCT05085756
Active Not Recruiting
Not Applicable
Transdiagnostic Internet Intervention to Improve Mental Health Among University Students
Karolinska Institutet
ClinicalTrials.gov
NCT05085756
Active Not Recruiting
Not Applicable
Transdiagnostic Internet Intervention to Improve Mental Health Among University...
Karolinska Institutet
NCT05131919
Active Not Recruiting
Phase 2
Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers
Merck Sharp & Dohme LLC
ClinicalTrials.gov
NCT05131919
Active Not Recruiting
Phase 2
Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal...
Merck Sharp & Dohme LLC
NCT05356364
Completed
Not Applicable
Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE)
Henry Ford Health System
ClinicalTrials.gov
NCT05356364
Completed
Not Applicable
Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting...
Henry Ford Health System
NCT05509660
Completed
Not Applicable
Transdiagnostic Internet Intervention to Improve Mental Health Among University Students: Pilot Study
Karolinska Institutet
ClinicalTrials.gov
NCT05509660
Completed
Not Applicable
Transdiagnostic Internet Intervention to Improve Mental Health Among University...
Karolinska Institutet
NCT06430333
Recruiting
Phase 2
Sleep to Reduce Incident Depression Effectively in Peripartum
Henry Ford Health System
ClinicalTrials.gov
NCT06430333
Recruiting
Phase 2
Sleep to Reduce Incident Depression Effectively in Peripartum
Henry Ford Health System
NCT06591559
Completed
Not Applicable
Up, Down, and All Around: Evaluating Mobility Devices for Young Children With Developmental Disabilities and Delays
National Center for Advancing Translational Sciences (NCATS)
ClinicalTrials.gov
NCT06591559
Completed
Not Applicable
Up, Down, and All Around: Evaluating Mobility Devices for Young Children With De...
National Center for Advan...
NCT07612683
Not Yet Recruiting
Not Applicable
Pulmonary Artery Catheters in Cardiac Surgery
Medical Research Future Fund
ClinicalTrials.gov
NCT07612683
Not Yet Recruiting
Not Applicable
Pulmonary Artery Catheters in Cardiac Surgery
Medical Research Future F...
NCT06095505
Recruiting
Phase 2
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Puma Biotechnology, Inc.
ClinicalTrials.gov
NCT06095505
Recruiting
Phase 2
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Puma Biotechnology, Inc.
NCT06369285
Recruiting
Phase 2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Puma Biotechnology, Inc.
ClinicalTrials.gov · CTIS (EMA)
NCT06369285
Recruiting
Phase 2
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-p...
Puma Biotechnology, Inc.
NCT01493544
Completed
Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America
AstraZeneca
ClinicalTrials.gov
NCT01493544
Completed
-
Prevalence Study and Regular Practice Among General Practitioners in Populations...
AstraZeneca
Result Breakdown
Status
Completed
8 (40%)
Recruiting
5 (25%)
Active, not recruiting
3 (15%)
Unknown
2 (10%)
Terminated
1 (5%)
Not yet recruiting
1 (5%)
Phase
not_applicable
10 (50%)
Phase 2
6 (30%)
Not Specified
3 (15%)
Phase 3
1 (5%)
Top Conditions
Insomnia
3 (15%)
Psychological Disorder
2 (10%)
Depression
2 (10%)
Show 7 more
Top Sponsors
Henry Ford Health System
3 (15%)
AstraZeneca
2 (10%)
National Institute of Allergy and Infectious Diseases (NIAID)
2 (10%)
Show 7 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease